STAAR Operating Margin from 2010 to 2024
| STAA Stock | USD 28.18 0.12 0.43% |
Check STAAR Surgical financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among STAAR Surgical's main balance sheet or income statement drivers, such as Depreciation And Amortization of 2.9 M, Interest Expense of 3 M or Total Revenue of 338.5 M, as well as many indicators such as Price To Sales Ratio of 19.64, Dividend Yield of 0.0 or PTB Ratio of 26.66. STAAR financial statements analysis is a perfect complement when working with STAAR Surgical Valuation or Volatility modules.
STAAR | Operating Margin |
Latest STAAR Surgical's Operating Margin Growth Pattern
Below is the plot of the Operating Profit Margin of STAAR Surgical over the last few years. It is STAAR Surgical's Operating Profit Margin historical data analysis aims to capture in quantitative terms the overall pattern of either growth or decline in STAAR Surgical's overall financial position and show how it may be relating to other accounts over time.
| View | Last Reported 0.06 % | 10 Years Trend |
|
Operating Profit Margin |
| Timeline |
STAAR Operating Margin Regression Statistics
| Arithmetic Mean | 0.03 | |
| Coefficient Of Variation | 251.41 | |
| Mean Deviation | 0.07 | |
| Median | 0.04 | |
| Standard Deviation | 0.09 | |
| Sample Variance | 0.01 | |
| Range | 0.2192 | |
| R-Value | 0.69 | |
| Mean Square Error | 0 | |
| R-Squared | 0.47 | |
| Significance | 0 | |
| Slope | 0.01 | |
| Total Sum of Squares | 0.10 |
STAAR Operating Margin History
About STAAR Surgical Financial Statements
STAAR Surgical stakeholders use historical fundamental indicators, such as STAAR Surgical's Operating Margin, to determine how well the company is positioned to perform in the future. Although STAAR Surgical investors may analyze each financial statement separately, they are all interrelated. For example, changes in STAAR Surgical's assets and liabilities are reflected in the revenues and expenses on STAAR Surgical's income statement, which ultimately affect the company's gains or losses. Understanding these patterns can help in making the right long-term investment decisions in STAAR Surgical. Please read more on our technical analysis and fundamental analysis pages.
STAAR Surgical Company, together with its subsidiaries, designs, develops, manufactures, markets, and sells implantable lenses for the eye, and companion delivery systems to deliver the lenses into the eye. STAAR Surgical Company was incorporated in 1982 and is headquartered in Lake Forest, California. Staar Surgical operates under Medical Instruments Supplies classification in the United States and is traded on NASDAQ Exchange. It employs 692 people.
Also Currently Popular
Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.When determining whether STAAR Surgical offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of STAAR Surgical's financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of Staar Surgical Stock. Outlined below are crucial reports that will aid in making a well-informed decision on Staar Surgical Stock:Check out the analysis of STAAR Surgical Correlation against competitors. For information on how to trade STAAR Stock refer to our How to Trade STAAR Stock guide.You can also try the Equity Analysis module to research over 250,000 global equities including funds, stocks and ETFs to find investment opportunities.
Is Health Care Equipment & Supplies space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of STAAR Surgical. If investors know STAAR will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about STAAR Surgical listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Quarterly Earnings Growth 1.018 | Earnings Share 0.44 | Revenue Per Share 6.962 | Quarterly Revenue Growth 0.103 | Return On Assets 0.0339 |
The market value of STAAR Surgical is measured differently than its book value, which is the value of STAAR that is recorded on the company's balance sheet. Investors also form their own opinion of STAAR Surgical's value that differs from its market value or its book value, called intrinsic value, which is STAAR Surgical's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because STAAR Surgical's market value can be influenced by many factors that don't directly affect STAAR Surgical's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between STAAR Surgical's value and its price as these two are different measures arrived at by different means. Investors typically determine if STAAR Surgical is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, STAAR Surgical's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.